Yahoo Finance • last month
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • last month
BALA CYNWYD, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story
Yahoo Finance • last month
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • last month
BALA CYNWYD, Pa., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story
Yahoo Finance • last month
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • last month
NEW YORK CITY and NEW ORLEANS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Y-mAbs Therapeutic... Full story
Yahoo Finance • last month
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story
Yahoo Finance • 2 months ago
Y-mAbs Therapeutics, Inc., a biopharmaceutical company focused on developing innovative antibody-based cancer therapies, has recently become the subject of significant market attention. The company, known for its FDA-approved drug Danyelza... Full story
Yahoo Finance • 2 months ago
Volume analysis on 2025-08-08: stocks with an unusual volume in today's session. [unusualvolume] UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 46.49% Today's trading... Full story
Yahoo Finance • 2 months ago
Investing.com - Y mAbs Therapeutics (NASDAQ: YMAB) reported second quarter EPS of $-0.07, $0.19 better than the analyst estimate of $-0.26. Revenue for the quarter came in at $19.53M versus the consensus estimate of $18.37M. Y mAbs Ther... Full story
Yahoo Finance • 2 months ago
Reported Total Revenues of $19.5 million for the second quarter of 2025, exceeding the high end of the Company’s guidance range of between $17 million and $19 millionSERB Pharmaceuticals to acquire Y-mAbs in $412.0 million transaction; tra... Full story
Yahoo Finance • 2 months ago
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based ther... Full story
Yahoo Finance • 2 months ago
Discover the stocks with unexpected trading volume in today's session on the US markets. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT TNON [https://www.chartmill.com/stock/quote/TNON/profile] 7.14% The... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 2 months ago
BALA CYNWYD, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story
Yahoo Finance • 2 months ago
Company Logo Leptomeningeal metastases (LM), the spread of cancer to the brain's and spinal cord's protective tissues, pose severe challenges, stemming from cancers like breast and lung. Rising cancer survival rates have increased LM inci... Full story
Yahoo Finance • 3 months ago
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a biotechnology company with a market capitalization of $192 million and a strong financial health rating according to InvestingPro, held its annual meeting of stockholders on Friday, July 11, where... Full story
Yahoo Finance • 4 months ago
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a market capitalization of $213.34 million, is navigating a complex landscape in the oncology therapeutics market. The company, known for its focus... Full story
Yahoo Finance • 4 months ago
Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugat... Full story
Yahoo Finance • 4 months ago
PRINCETON, N.J., May 26, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunothe... Full story